AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
13.47
-0.15 (-1.10%)
At close: Dec 5, 2025, 4:00 PM EST
13.32
-0.15 (-1.14%)
After-hours: Dec 5, 2025, 6:01 PM EST
AngioDynamics Market Cap
AngioDynamics has a market cap or net worth of $554.96 million as of December 5, 2025. Its market cap has increased by 98.48% in one year.
Market Cap
554.96M
Enterprise Value
525.80M
1-Year Change
98.48%
Ranking
Category
Stock Price
$13.47
Market Cap Chart
Since June 1, 2004, AngioDynamics's market cap has increased from $151.60M to $554.96M, an increase of 266.07%. That is a compound annual growth rate of 6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 561.10M | 50.75% |
| Dec 31, 2024 | 372.20M | 19.14% |
| Dec 29, 2023 | 312.40M | -41.99% |
| Dec 30, 2022 | 538.50M | -49.48% |
| Dec 31, 2021 | 1.07B | 83.22% |
| Dec 31, 2020 | 581.80M | -3.40% |
| Dec 31, 2019 | 602.30M | -19.40% |
| Dec 31, 2018 | 747.30M | 22.39% |
| Dec 29, 2017 | 610.60M | -1.86% |
| Dec 30, 2016 | 622.20M | 41.28% |
| Dec 31, 2015 | 440.40M | -35.02% |
| Dec 31, 2014 | 677.70M | 12.04% |
| Dec 31, 2013 | 604.90M | 57.40% |
| Dec 31, 2012 | 384.30M | 2.92% |
| Dec 30, 2011 | 373.40M | -2.48% |
| Dec 31, 2010 | 382.90M | -2.62% |
| Dec 31, 2009 | 393.20M | 17.90% |
| Dec 31, 2008 | 333.50M | -27.09% |
| Dec 31, 2007 | 457.40M | 36.21% |
| Dec 29, 2006 | 335.80M | 7.52% |
| Dec 30, 2005 | 312.30M | 23.20% |
| Dec 31, 2004 | 253.50M | 67.22% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |